Publication Name	World Journal of Diabetes
Manuscript ID	31106
Country	United States

Received	2016-10-30 14:58
Peer-Review Started	2016-11-03 11:06
To Make the First Decision	2017-02-15 12:07
Return for Revision	2017-02-20 09:47
Revised	2017-03-12 08:02
Second Decision	2017-04-12 15:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-04-19 17:04
Articles in Press	2017-04-19 17:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-07-17 07:57
Publish the Manuscript Online	2017-08-11 07:16

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Retrospective Cohort Study
Article Title	Prevalence of obesity and diabetes in patients with schizophrenia
Manuscript Source	Invited Manuscript
All Author List	Aniyizhai Annamalai, Urska Kosir and Cenk Tek
Funding Agency and Grant Number	Funding Agency Grant Number National Institute of Diabetes and Digestive and Kidney Diseases R01DK093924
Corresponding Author	Aniyizhai Annamalai, MD, Assistant Professor, Department of Psychiatry, Yale School of Medicine, 333 Cedar St, New Haven, CT 06519, United states. aniyizhai.annamalai@yale.edu
Key Words	Schizophrenia; Antipsychotic; Diabetes; Body mass index; Obesity
Core Tip	This study compares obesity and diabetes rates between schizophrenia patients treated in a community mental health center and a local population control. It demonstrates that prevalence of obesity and diabetes is significantly higher in patients with schizophrenia, which is consistent with previous research. In this cross-sectional study, second generation antipsychotic use and antipsychotic dosage were not correlated with obesity categories or diabetes status. This implies that antipsychotics alone may not be responsible for the increased diabetes risk in schizophrenia patients. Many factors may contribute to risk, including an inherent vulnerability to diabetes in schizophrenia patients that has been seen in earlier studies.
Publish Date	2017-08-11 07:16
Citation	Annamalai A, Kosir U, Tek C. Prevalence of obesity and diabetes in patients with schizophrenia. World J Diabetes 2017; 8(8): 390-396
URL	http://www.wjgnet.com/1948-9358/full/v8/i8/390.htm
DOI	http://dx.doi.org/10.4239/wjd.v8.i8.390

Full Article (PDF)	WJD-8-390.pdf
Full Article (Word)	WJD-8-390.doc
Manuscript File	31106-Review.docx
Answering Reviewers	31106-Answering reviewers.pdf
Audio Core Tip	31106-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	31106-Conflict-of-interest statement.pdf
Copyright License Agreement	31106-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	31106-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	31106-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	31106-Institutional review board statement.pdf
Peer-review Report	31106-Peer-review(s).pdf
Scientific Misconduct Check	31106-Scientific misconduct check.pdf
Scientific Editor Work List	31106-Scientific editor work list.pdf